These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24128880)

  • 1. Astrocyte loss and astrogliosis in neuroinflammatory disorders.
    Hostenbach S; Cambron M; D'haeseleer M; Kooijman R; De Keyser J
    Neurosci Lett; 2014 Apr; 565():39-41. PubMed ID: 24128880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMO spectrum of disorders: a paradigm for astrocyte-targeting autoimmunity and its implications for MS and other CNS inflammatory diseases.
    Vaknin-Dembinsky A; Karussis D; Avichzer J; Abramsky O
    J Autoimmun; 2014 Nov; 54():93-9. PubMed ID: 25129503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features in anterior visual pathway in neuromyelitis optica.
    Hokari M; Yokoseki A; Arakawa M; Saji E; Yanagawa K; Yanagimura F; Toyoshima Y; Okamoto K; Ueki S; Hatase T; Ohashi R; Fukuchi T; Akazawa K; Yamada M; Kakita A; Takahashi H; Nishizawa M; Kawachi I
    Ann Neurol; 2016 Apr; 79(4):605-24. PubMed ID: 26836302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.
    Marignier R; Nicolle A; Watrin C; Touret M; Cavagna S; Varrin-Doyer M; Cavillon G; Rogemond V; Confavreux C; Honnorat J; Giraudon P
    Brain; 2010 Sep; 133(9):2578-91. PubMed ID: 20688809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Astrocytopathy in neuromyelitis optica, multiple sclerosis and Baló's disease].
    Matsushita T; Masaki K; Suzuki S; Matsuoka T; Yonekawa T; Wu XM; Tabira T; Iwaki T; Kira J
    Rinsho Shinkeigaku; 2011 Nov; 51(11):898-900. PubMed ID: 22277409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
    Kira J
    J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Demonstration of an Aqp4/Tgf-beta 1 Pathway in Murine Astrocytes Holds Implications for Both Neuromyelitis Optica and Progressive Multiple Sclerosis.
    Nataf S
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.
    Vincent T; Saikali P; Cayrol R; Roth AD; Bar-Or A; Prat A; Antel JP
    J Immunol; 2008 Oct; 181(8):5730-7. PubMed ID: 18832732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The astrocyte in multiple sclerosis revisited.
    Brosnan CF; Raine CS
    Glia; 2013 Apr; 61(4):453-65. PubMed ID: 23322421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.
    Parratt JD; Prineas JW
    Mult Scler; 2010 Oct; 16(10):1156-72. PubMed ID: 20823059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.
    Massey J; Buckland ME; Barnett Y; Sutton I
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27469383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination.
    Sharma R; Fischer MT; Bauer J; Felts PA; Smith KJ; Misu T; Fujihara K; Bradl M; Lassmann H
    Acta Neuropathol; 2010 Aug; 120(2):223-36. PubMed ID: 20532539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration.
    Winkler A; Wrzos C; Haberl M; Weil MT; Gao M; Möbius W; Odoardi F; Thal DR; Chang M; Opdenakker G; Bennett JL; Nessler S; Stadelmann C
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33645550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.